Class Action Lawsuit Against Geron Corporation
On May 9, 2025, Levi & Korsinsky, LLP reached out to investors of Geron Corporation (NASDAQ: GERN) regarding a
class action securities lawsuit. This legal action is aimed at those who have experienced losses linked to alleged securities fraud between February 28, 2024, and February 25, 2025.
What This Lawsuit Is About
The class action is focused on facts that emerged from claims stating that Geron Corporation failed to properly inform investors about the commercial prospects and growth potential of its drug,
Rytelo (imetelstat). The lawsuit underscores that Geron’s management had made positive assertions regarding the market need for Rytelo and its sales strategies, downplaying potential risks associated with its monitoring requirements and competition.
According to the announcement on February 26, 2025, the company revealed disappointing financial outcomes for the fourth quarter of fiscal year 2024, stating that Rytelo's growth had stagnated. The causes were attributed to factors such as market seasonality, declining consumer awareness, and competitive pressure. As a result, the stock saw a dramatic plunge from $2.37 per share on February 25 to $1.61 on February 26, losing about
32.07% of its value overnight.
Important Information for Investors
Investors who suffered losses during this critical timeframe have until
May 12, 2025, to request to be appointed as lead plaintiffs in this lawsuit. However, participation in any potential recovery does not necessitate being a lead plaintiff. One of the key benefits outlined is that class members could be entitled to compensation without any cost or obligation involved.
Why Choose Levi & Korsinsky
With over 20 years of experience successfully securing compensations for shareholders, Levi & Korsinsky is recognized as a leading firm in complex securities litigation. Their transparent and client-focused approach aims to provide aggrieved investors with superior representation. In fact, for seven consecutive years, the firm has been featured in the Top 50 list of securities litigation firms by ISS Securities Class Action Services.
If you believe you were affected by Geron's actions, now is the time to act. For further communication, you can reach out directly to
Joseph E. Levi, Esq. via email or phone at the provided contact information.
As the deadlines approach, ensure you stay informed to protect your investments. Follow the link
here to submit your request and gain further insights about the situation.